Max Robotics — Global Service Robot Directory + US Certification

About

Pradip Shahi Thakuri is a biomedical researcher whose work sits at the intersection of cancer biology, drug discovery, and tissue engineering. His research has focused primarily on developing advanced three-dimensional tumor models — particularly tumor spheroids — to more accurately replicate the complex biology of solid tumors and improve the reliability of preclinical drug screening. Frustrated by the limitations of conventional monolayer cell cultures in predicting real-world drug efficacy, Thakuri pioneered innovative approaches using aqueous two-phase systems and robotic microprinting technologies to mass-produce uniformly sized spheroids compatible with high-throughput screening platforms. His 2016 paper on multiparametric oncology drug screening has garnered 50 citations, establishing him as a key contributor to this niche but critical field. Beyond spheroid development, Thakuri has explored the tumor microenvironment's dynamic role in cancer progression, as demonstrated by his 2020 organotypic breast tumor model study. His work also extends into stem cell biology, where microprinted colony systems revealed how colony size influences neural differentiation. Collectively, his research offers practical tools that bridge the gap between laboratory discovery and clinical translation in oncology.